News
AstraZeneca has produced some fresh data to back up its blockbuster ambitions for camizestrant, tying the oral SERD to a 56% ...
KORE Group Holdings, Inc. ("KORE" or the "Company"), a global leader in Internet of Things ("IoT") Solutions and IoT Connectivity provider, today announced the appointment of Anthony Bellomo as ...
Grünenthal today announced the acquisition of the commercial rights to Cialis® (tadalafil) in Mexico, Brazil and Colombia from Eli Lilly and Company. Over the next few years, Grünenthal and Lilly will ...
Eli Lilly is a global healthcare giant, generating strong growth from a diverse portfolio of blockbuster medications. Viking ...
The latest readout from the BREAKWATER study showed "unprecedented" median overall survival of 30.3 months for ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...
Explore more
With IRS tax refunds set to arrive, averaging around $3,000, many Americans are weighing the best ways to use the extra cash.
A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...
Hims & Hers is evolving beyond its original focus, aggressively expanding into peptides and GLP-1. Read why I reiterate my ...
Strathcona Resources (OTCPK:STHRF) said Friday it formally launched its offer to acquire MEG Energy (OTCPK:MEGEF) that values ...
Income investing isn’t meant to create fabulous wealth in a month or even a year. After a quarter-century of successful ...
Stocks were boosted in May by easing trade tensions, solid corporate earnings and signs the U.S. economy remains resilient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results